Clincosm LogoSign in Get a demo

oropharyngeal squamous cell carcinoma

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A New Mutational and Epigenetic Signature to Predict Early OPSCC

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
    • Aviano, Italy
    • +4 more
    Nov 14, 2023

    Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +14 more
    • Biospecimen Collection
    • +9 more
    • (no location specified)
    Oct 10, 2023

    People Living With HIV, Oral and Oropharyngeal Cancer, and

    Not yet recruiting
    • HIV Infections
    • +2 more
    • Group Meeting (Focus Group)
    • Questionnaires
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2023

    Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in China (Tislelizumab, Albumin-Bound Paclitaxel,

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Oropharyngeal Squamous Cell Carcinoma
    • Beijing, Beijing, China
    • +13 more
    Aug 22, 2023

    Oropharyngeal Squamous Cell Carcinoma Trial in Philadelphia (adjuvant radiotherapy)

    Recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • adjuvant radiotherapy
    • Philadelphia, Pennsylvania
    • +2 more
    Feb 2, 2023

    Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage

    Recruiting
    • Basaloid Squamous Cell Carcinoma
    • +7 more
    • Birmingham, Alabama
    • +469 more
    Jan 28, 2023

    Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Squamous Cell Carcinoma,

    Active, not recruiting
    • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +19 more
    • Cetuximab
    • +5 more
    • Birmingham, Alabama
    • +255 more
    Dec 30, 2022

    Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

    Not yet recruiting
    • Oropharyngeal Cancer
    • +10 more
    • (no location specified)
    Dec 14, 2022

    Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

    Recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 22, 2022

    Oropharyngeal Squamous Cell Carcinoma, Supraglottic Squamous Cell Carcinoma Trial in Charlottesville (Transoral robotic surgery)

    Active, not recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • Supraglottic Squamous Cell Carcinoma
    • Transoral robotic surgery
    • Charlottesville, Virginia
      University of Virginia Health System
    Nov 20, 2022

    The Role of Circulating Tumour DNA in Head and Neck Cancer

    Recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • Human Papillomavirus (HPV)
      • Dundee, Dd2 1sg, United Kingdom
      • +4 more
      Sep 13, 2022

      Laryngeal Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in

      Not yet recruiting
      • Laryngeal Squamous Cell Carcinoma
      • +2 more
      • Sentinel lymph node biopsy guided selective elective neck irradiation
      • Standard elective neck irradiation
      • Amsterdam, Netherlands
      • +5 more
      Aug 30, 2022

      Oropharyngeal Squamous Cell Carcinoma Trial in Worldwide (Radiation, Cisplatin, Durvalumab)

      Recruiting
      • Oropharyngeal Squamous Cell Carcinoma
      • Radiation
      • +3 more
      • Brussels, Belgium
      • +25 more
      Aug 8, 2022

      Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in

      Recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • +2 more
      • Optimisation of dental implant sites protection from irradiation
      • Strasbourg, France
        Institut de cancérologie Strasbourg Europe
      Aug 2, 2022

      Post-treatment Surveillance in HPV+ Oropharyngeal SCC

      Recruiting
      • HPV
      • Oropharyngeal Squamous Cell Carcinoma
      • Screening
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jun 8, 2022

      Head Neck Cancer, Oropharynx Cancer, Oropharyngeal Squamous Cell Carcinoma Trial in United States (Intensity modulated

      Recruiting
      • Head and Neck Cancer
      • +2 more
      • Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)
      • Baltimore, Maryland
      • +5 more
      Apr 26, 2022

      Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in Guangzhou, Guanzhou (sintilimab, paclitaxel,

      Recruiting
      • Oral Squamous Cell Carcinoma
      • Oropharyngeal Squamous Cell Carcinoma
      • sintilimab, paclitaxel, carboplatin
      • Surgical resection
      • Guangzhou, Guangdong, China
      • +1 more
      Feb 23, 2022

      Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical

      Active, not recruiting
      • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8
      • +8 more
      • Durvalumab
      • +6 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Dec 7, 2021

      Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (Transoral Robotic Surgery (TORS) or Radiotherapy, Chemotherapy and

      Recruiting
      • Oropharyngeal Squamous Cell Carcinoma
      • Transoral Robotic Surgery (TORS) or Radiotherapy
      • +4 more
      • Chicago, Illinois
        University of Chicago Medical Center
      Nov 12, 2021

      Oral Cavity Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in Guangzhou

      Recruiting
      • Oral Cavity Squamous Cell Carcinoma
      • +2 more
      • Sintilimab, Nab-paclitaxel, Carboplatin
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Oct 20, 2021

      Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in

      Recruiting
      • Oropharyngeal Squamous Cell Carcinoma
      • +3 more
        • Rochester, Minnesota
        • +1 more
        Oct 5, 2021

        Head Neck Cancer, Oropharyngeal Squamous Cell Carcinoma Trial in London (Radiation, Trans-Oral Surgery (TOS) + Neck Dissection)

        Recruiting
        • Head and Neck Cancer
        • Oropharyngeal Squamous Cell Carcinoma
        • Radiation
        • Trans-Oral Surgery (TOS) + Neck Dissection
        • London, Ontario, Canada
          London Regional Cancer Program
        Sep 2, 2020

        Oropharyngeal Squamous Cell Carcinoma Trial in Nijmegen (RGD PET/CT)

        Recruiting
        • Oropharyngeal Squamous Cell Carcinoma
        • RGD PET/CT
        • Nijmegen, Gelderland, Netherlands
          Radboudumc
        Jan 6, 2020

        Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial (Computed Tomography, Positron

        Withdrawn
        • Oropharyngeal Squamous Cell Carcinoma
        • HPV Positive Oropharyngeal Squamous Cell Carcinoma
        • Computed Tomography
        • Positron Emission Tomography
        • (no location specified)
        Aug 5, 2019

        Radioguided Selective Neck Dissection for Staging and Treatment

        Unknown status
        • Oral Cavity Squamous Cell Carcinoma
        • Oropharyngeal Squamous Cell Carcinoma
          • Ferrara, Italy
            University Hospital of Ferrara
          Oct 31, 2018